Nath Bio-genes (india) Ltd. · NSE:NATHBIOGEN
Nath Bio-genes (india) — FY2022 Earnings Presentation
28 slides from Nath Bio-genes (india)'s earnings presentation, May 30, 2022
Slide 1: Nath Bio-Genes (I) Ltd. – Presentation on Audited Financial Results
86. Se. Nath Bio-Genes (I) Ltd. (CIN L01110MH1993PLC072842) 30th May 2022 The Manager-Listing The Manager-Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code-537291 ,
Slide 2: Q4 & FY22 Performance
Q4 & FY22 Performance 8 oe S. Nath Bio-Genes (I) Ltd. erat ae, ate
Slide 3: Safe Harbour
Safe Harbour Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actua
Slide 4: Strategic Update
Strategic Update FY22 Season Update New Products Developments/Launches Cotton packets sold 11.90 Lacs Kharif Season in progress Field Crop, Vegetable sales lined up Non-Cotton; Non-Paddy Field Crop grew by New products launched in Cotton, Paddy and Vegetables 27%. Corporate Actions Working Capital P
Slide 5: Strong Operating and Financial Performance
Strong Operating and Financial Performance o Non - cotton, non - paddy portfolio contributed 40% to revenue Operating Performance o Cotton and Paddy portfolio contribution reduced from 62% to 60% o Cotton sales maintained YoY o Revenue down by 9.50% YoY due to reduced paddy sales o Contribution marg
Slide 6: Managing Headwinds
Managing Headwinds Impact of Covid o Certain advances given to farmers during the entire COVID period became non recoverable; As a matter of prudence provisions made for such advances o Efforts were made to adjust them in future production; Efforts will be continue to recover/adjust advances in futu
Slide 7: Income Statement
Income Statement Particulars (INR Mn) FY22 FY21 % Change (YoY) Q4FY22 Q4FY21 % Change (YoY) Total Revenue 2,783 3,076 -9.5% 272 550 -50.5% Gross Profit 1,544 1,715 -9.9% 197 310 -36.4% Gross Margin (%) 55.5% 55.8% -30bps 72.3% 56.4% 1590bps EBITDA 373 667 -44.0% -212 111 - EBITDA Margin (%) 13.4% 21
Slide 8: Stable Balance Sheet Despite Growth
Stable Balance Sheet Despite Growth Assets (INR Mn) FY22 FY21 Liabilities (INR Mn) FY22 FY21 Fixed Assets 2,449 2,469 Share Capital 190 190 Financial Assets 51 53 Reserves & Surplus 5,229 5,943 Other Non-current Assets 218 134 Long-Term Borrowings 7 7 Inventories 2,203 2,263 Long-term Provisions 26
Slide 9: Segment wise Operating Performance
Segment wise Operating Performance Products Metric FY22 FY21 YOY Growth FY20 Cotton Packets in lakhs 11.90 12.24 -2.8% 11.66 Paddy Quintals 59,176 83,839 -29.4% 74,116 Other Crops (Bajra, Quintals 29,963 34,195 -12.4% 31,041 Maize,) o Cotton sales maintained on YoY basis o Paddy quantity reduced by
Slide 10: Segmental Revenue Contribution- Cotton + Paddy share reducing
Segmental Revenue Contribution- Cotton + Paddy share reducing FY21 Revenue FY22 Revenue INR 3,076Mn INR 2,784 Mn FY21 FY22 Cotton, 30% Cotton, 30% Others, 38% Others, 41% Paddy, 32% Paddy, 28% Cotton Paddy Others Cotton Paddy Others • include: Jowar, Bajra, Maize, Mustard, Wheat
Slide 11: Highly Ranked Cotton Products – Aim to Gain Market Share
Highly Ranked Cotton Products – Aim to Gain Market Share o Volume growth of 10-15% projected for FY23 o Special Campaign being undertaken to educate farmers 3 YEAR OUTLOOK: 20% + Growth CAGR Progress of Acreage under COTTON BT (in Lk Hectare) - STATE-WISE 9 Cotton Products launched in last 5 years 8
Slide 12: Paddy: Strong Outlook
Paddy: Strong Outlook 3 YEAR OUTLOOK: o Volume growth projected at 15-20% in FY23 20% + Growth o Research Efforts underway for new products Presence of Paddy across India 10+ Key Products Key Markets Paddy Products launched in last 5 years Hybrid Vegetable Market Size: INR 25 – 30 Bn Loknath Bihar
Slide 13: Highly diversified vegetable Portfolio
Highly diversified vegetable Portfolio o Volume growth of 25-30% projected in FY23 3 YEAR OUTLOOK: o High Margin segment : 60%+ margins 30% + Growth o New products being launched o Vegetable vertical achieving results Hybrid Vegetable Market Size: INR 25 – 30 Bn Hybrid Vegetable Industry: Market B
Slide 14: Win Chi Win : Major growth booster
Win Chi Win : Major growth booster 3 YEAR OUTLOOK: o Volume growth of 15% projected in FY23. 30% + Growth o High Margin segment : 70%+ Margins o Territories enhanced to sustain growth Geographical Presence of Win Chi Win • A growth enhancer for • Concentrate on Plant Nutrient Segment for Cereals, Fr
Slide 15: Innovate, Help, Grow
Innovate, Help, Grow Innovate Help Grow (5 Year Performance] 45 150,000 45% New Seeds Developed in last 5 Employment Generated Revenue Growth years 100+ years 50,000 2.3x Contract Farmers EBITDA Growth till FY21 R&D Team experience #1-3 20,000+ 3.45x Direct Retailers PAT Growth till FY21 ICAR Trials
Slide 16: Focussed on Shareholder Value Creation
Focussed on Shareholder Value Creation Building A Strong Organisation; Evolved into a Dividend Paying Company Developing Innovative Products Making the Portfolio more Balanced Balance Sheet becoming Stronger Strategic Presence across Seed Value Chain Delivering strong growth despite an uncertain env
Slide 17: Working Capital Cycle
Working Capital Cycle All figures in INR mn FY22 FY21 Revenue 2,783 3,076 Inventories 2,203 2,263 Trade Receivables 879 1,094 Trade Payables 551 452 Net Working Capital 2,532 2,905 FY22 FY21 Inventory Days 289 268 Receivable Days 115 130 Payable Days 72 54 Working Capital Cycle 332 344 o Increase in
Slide 18: Corporate Overview
Corporate Overview 8 oe S. Nath Bio-Genes (I) Ltd. erat ae, ate
Slide 19: Strategy 4.0
Strategy 4.0 Altering strategy to create a more robust & de-risked business model Risks Change in Strategy Action Points o Portfolio Concentration o Limiting revenue contribution of any o Developing products in multiple Risk single crop to less than 25% food crops like Maize, Jowar, Bajra o Cotton &
Slide 20: Building a Strong Organisation
Building a Strong Organisation • Imbibing a culture of continuous growth and strong governance 500+ • Hiring industry experts in each key area of Employees operations – R&D, Finance, Supply-Chain • Empowered teams, well-aligned with organisation vision 150+ • Strong risk management framework New Emp
Slide 21: Developing Innovative Products
Developing Innovative Products Holistic Products to Address Problems of • World Class R&D Infrastructure • Launched 36 Innovative Products Developed Low Yields across Segments Climate Change • 8-10 new products in pipeline in cotton • 20+ new products in pipeline in Vegetables Pest Infestations Seed
Slide 22: Strategic Presence Across the Seed Value Chain
Strategic Presence Across the Seed Value Chain Genetic Resources/Germplasms 18,000+ Germplasm Library R&D 100+ years R&D Team experience New Seed Development ICAR Trials 36 done at Seed varieties launched in last 3 years Commercial Production this stage 50,000 Contract Farmers Marketing and Distribu
Slide 23: Appendix
Appendix 8 oe S. Nath Bio-Genes (I) Ltd. aaa ag, ae 22
Slide 24: Visionary Leadership; Attracting the Best Talent
Visionary Leadership; Attracting the Best Talent Mr. N Mr. Satish Nath Promoters are committed to sustainable Kagliwal Kagliwal MD growth and are working towards making Nath one Chairman of the best seeds company globally. Leadership Team Research & Product Development Nath leadership team shares th
Slide 25: Maintaining Profitability; Strong Balance Sheet
Maintaining Profitability; Strong Balance Sheet Net Debt (INR Mn) Net Worth (INR Mn) 6,133 5,576 5,420 888 5,076 4,692 679 659 576 3,033 478 363 207 1,071 1,213 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 -121 EBITDA Margin (%) PAT Margin (%) 18% 18% 21% 22% 17% 1
Slide 26: Historical Income Statement
Historical Income Statement Nath Bio-Genes’ P&L Statement Particulars (INR Mn) FY22 FY21 FY20 FY19 Total Revenue 2,783 3076 2799 2,309 Gross Profit 1,544 1715 1536 1,253 Gross Margin (%) 56% 56% 55% 54% EBITDA 373 667 547 433 EBITDA Margin (%) 13% 22% 20% 19% Depreciation 31 28 14 14 Finance Cost 10
Slide 27: Historical Balance Sheet
Historical Balance Sheet Assets (INR Mn)FY FY22 FY21 FY20 FY19 Liabilities FY22 FY21 FY20 FY19 Fixed Assets 2,449 2,469 2,460 2,317 Share Capital 190 190 190 190 Financial Assets 51 53 52 52 Reserves & Surplus 5,229 5,943 5,386 4,885 Other Non-current 218 134 15 20 Long-Term Borrowings 7 7 3 5 Asset
Slide 28: Thank You
Thank You CIN_NBIL_L01110MH1993PLC072842 For further information, please get in touch with: Sheetal Khanduja Monali Jain sheetal@GoIndiaadvisors.com monali@GoIndiaadvisors.com M:+91 97693 64166 M:+917597304020 27
Nath Bio-Genes (India) — FY2022 Earnings Presentation on 6ix